Featured Slider

David B. Vodušek (DBV): Can you tell us about your training and how you ended up looking after neurological patients with uro-neurological symptoms? David B. Vodušek (DBV): Can you tell us about your training and how you ended up looking after neurological patients with uro-neurological symptoms? Clare J Fowler (CJF): My early training included neurology at a junior level, but when it came to choosing a career path I was advised to pursue clinical neurophysiology, on the grounds that it could be a 'suitable' job for a woman with children. Furthermore, there was a UK shortage of consultant neurophysiologists.

or August 2017, we have selected: The Writing Group on behalf of the Edaravone (MCI-186) ALS 19 Study Group. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial. Lancet Neurol 2017;16:505-512. There is evidence that oxidative stress induced by free radicals is a key factor of progression in amyotrophic lateral sclerosis (ALS).

Memories from the 3rd EAN Congress in Amsterdam find yourself, a colleague or a friend in the Amsterdam photo-gallery        Amsterdam 2017: Memories from the 3rd EAN Congress – view the photo gallery was last modified: July 31st,… Continue Reading

the understanding or treatment of MS. David B. Vodušek (DBV): Can you tell us about your training and how you ended up looking after neurological patients with MS and pursuing research in MS? Per Soelberg Sorensen (PSS): When I was a young doctor, I was fascinated by neurology because of the way the neurologist would deduct where the lesion in the nervous system was located based on the history and objective examination. This was before the appearance of scanners.

For July 2017, we have selected: Fernandez HH, Factor SA, Hauser RA, et al. Randomized controlled trial of deutetrabenazine for tardive dyskinesia. Neurology 2017;88:2003-2010. Tardive dyskinesia (TD) is a relatively frequent complication of antipsychotic treatment. TD can be observed in any part of the body, can be very disabling, and often persists even after stopping the causative medication.

Amsterdam, 26 June 2017 – The Congress of the European Academy of Neurology (EAN) in Amsterdam received a royal visit today: H.M. Queen Máxima of the Netherlands attended the major scientific event at RAI Amsterdam, in which over 6,000 people… Continue Reading

Plenary Symposium 2: Presidential Symposium Main Auditorium, Sunday, June 25, 2017, 10:00-12:00 Chairperson Günther Deuschl, Kiel, Germany
Selma C Tromp, Nieuwegein, The Netherlands Moritz Romberg Lecture – Epilepsy: Where do we stand? Where are we headed?
Christian E. Elger, Bonn,… Continue Reading

The European Academy of Neurology is announcing its third congress from June 24th- June 27th at the RAI Congress Center in Amsterdam. We are expecting more than 6000 neurologists from Europe and all over the world for this outstanding annual event. The programme and the education committee of the EAN worked hard to create a program which will present cutting edge science and first class education for the general neurologist. The purpose is to present excellence in neurology and when the participants leave the congress they will know all about the current status and the important news in our field.

The Kingdom of the Netherlands, also known as Holland, has been densely populated from medieval times with the largest part of the population living in cities. Amongst these are many well-preserved gems like the university town of Leiden, where Rembrandt van Rijn was borne, Haarlem, the city of Frans Hals, the cheese town Alkmaar in the north, the Hansa town of Deventer in the east, the astute university city of Groningen in the north and Maastricht, the capital of the province of Limburg.

For June 2017, we have selected: Breitenstein C, Flöel A, Ziegler W, et al., for the FCET2EC study group. Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomized, open-label, blinded-endpoint, controlled trial in health-care setting. Lancet Neurol 2017;389:1528-1538. Speech and language impairments are among the most disabling symptoms after a stroke. Patients with aphasia persisting 6 months (chronic aphasia) after a stroke are not infrequent (20%). Hence, the social and economic impact of chronic aphasia is substantial.

The revision of the International Classification of Diseases (ICD) is a highly complicated process handled by experts in statistics at the WHO in Geneva. The influence of Neurological Societies onto the creation of a revision is through the accredited Societies which are for Neurology and Stroke the World Federation of Neurology (WFN) and the World Stroke Organisation (WSO). They are working within the Topic Advisory Group Neurology (TAGN) and can only make recommendations to the experts. April 2011 the TAGN advised to shift the section “Cerebrovascular diseases” covering all types of stroke from the “Diseases of the circulatory system” class (as it is in ICD-10) into the “Diseases of the nervous system” class (as it proposed in the draft ICD-11). This corresponds to a change of the statistical and legal placement of stroke from Internal Medicine to Neurology. This was then executed accordingly 5 years ago and stroke went under the neurological diseases (08) in the beta-version of the ICD-11. Neurologists all over the world agreed with this decision.

or May 2017 we have selected: Kermer P, Eschenfelder CC, Diener H-C, et al.  Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany – A national case collection. International Journal of Stroke 2017; doi: 10.1177/1747493017701944. The use of non-vitamin-K-antagonist oral anticoagulants (NOACs) to prevent stroke in patients with atrial fibrillation is increasing worldwide.

Romania  geographically belongs to Eastern Europe, but by history, tradition and culture it is perfectly expressing the values of an United Europe. With the Danube River as a large part of our Southern border (with Serbia and Bulgaria), the Danube… Continue Reading

The annual congress is the most important event of our Society. This year European and International Neurologists are invited to attend the third EAN congress in Amsterdam, The Netherlands, June 24-27. Literally hundreds of EAN-members are involved to in the preparation of this congress. I wanted to explain to our members how the congress programme is developed. In its third year of existence of the Society, some of the preparation has come to routine but most of the tasks are highly challenging year after year as one of the aims of the Society is to have new innovations every year.

For April 2017, we have selected: Chen H, Kwong JC, Copes R, et al.  Living near major roads and the incidence of dementia, Parkinson’s disease, and multiple sclerosis: a population-based cohort study. Lancet 2017:389;718-726. Some studies have suggested that smog and noise can play a role in the pathogenesis of neurodegenerative disorders by inducing oxidative stress, neuroinflammation, microglia and neuronal antibody activation.